Bio Essence Corp
OTC:BIOE
Balance Sheet
Balance Sheet Decomposition
Bio Essence Corp
Bio Essence Corp
Balance Sheet
Bio Essence Corp
| Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
2
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
2
|
1
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Total Assets |
2
N/A
|
1
-46%
|
2
+124%
|
2
-20%
|
2
-8%
|
2
-9%
|
3
+78%
|
0
-90%
|
|
| Liabilities | |||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accrued Liabilities |
0
|
0
|
0
|
1
|
0
|
0
|
1
|
1
|
|
| Short-Term Debt |
0
|
0
|
1
|
1
|
2
|
3
|
2
|
1
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
1
|
1
|
2
|
3
|
4
|
2
|
3
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
2
|
2
|
1
|
1
|
2
|
0
|
|
| Total Liabilities |
0
N/A
|
1
+138%
|
3
+296%
|
4
+7%
|
4
+14%
|
5
+16%
|
4
-8%
|
3
-26%
|
|
| Equity | |||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
3
|
4
|
6
|
7
|
7
|
8
|
9
|
10
|
|
| Additional Paid In Capital |
4
|
5
|
5
|
5
|
5
|
5
|
7
|
7
|
|
| Total Equity |
2
N/A
|
0
-89%
|
1
N/A
|
2
-64%
|
2
-36%
|
3
-33%
|
2
+49%
|
3
-79%
|
|
| Total Liabilities & Equity |
2
N/A
|
1
-46%
|
2
+124%
|
2
-20%
|
2
-8%
|
2
-9%
|
3
+78%
|
0
-90%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
38
|
38
|
38
|
33
|
33
|
33
|
38
|
38
|
|